Skip to main content

Genaissance Study Reports 14 Variations per Human Gene

NEW YORK, July 12 - Genaissance Pharmaceuticals announced Thursday that it identified an average of 14 different versions of every gene it examined in a recent study, which will appear in the July 20 issue of Science

The report unveils previously unknown variations in human genes, Genaissance CEO, Gualberto Ruano, said at a press conference on the study. Looking at 82 individuals from 4 different groups of diverse origin, the company identified 3,899 SNPs within 313 genes.

Ruano said that, on average, the company found 14 versions of each gene but that the number of variations identified for each gene range from two to 53. 

If there are 30,000 sites where genes reside on the human genome and an average of 14 versions for each, then the array of genetic elements that complement the genome is in the range of 500,000, Ruano noted.

Genaissance CTO Gerald Vovis added that 95 percent of the variability in the 313 genes that the company identified through its industrialized screening process was novel. 

Vovis said that the company, which is based in New Haven, Conn., has examined 4,000 genes to date and ultimately intends to explore every human gene for variation.

 

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.